Clinical Trials Browser

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Colonic Neoplasms, Rectal Neoplasms

Locally Recurrent Skin Squamous Cell Carcinoma

Skin Neoplasms

Colorectal Neoplasms

Head and Neck Neoplasms, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Colorectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Advanced Colorectal Cancer

Mouth Neoplasms

Squamous Cell Carcinoma of Head and Neck

Solid Tumors

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Carcinoma, Squamous Cell, Laryngeal Diseases

Adenocarcinoma Of Esophagus, Barrett Esophagus

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Spinocerebellar Degenerations, Colorectal Neoplasms

RAS Wild Type mCRC

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Colorectal Neoplasms

Clinical Trials

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

ERBIOTAX

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

BRIDGE

ANCHOR-CRC

KANDLELIT-014

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

EACH

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

CACTUX

NAUTICALCRC

GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

SLURP

SEAMARK

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

DARTBOARD

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer